# Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification

> **NCT01193504** · PHASE4 · UNKNOWN · sponsor: **Innovative Medical** · enrollment: 100 (estimated)

## Conditions studied

- Pseudophakia
- Cataract Surgery

## Interventions

- **DRUG:** Pred Forte
- **DRUG:** Lotemax

## Key facts

- **NCT ID:** NCT01193504
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01193504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01193504, "Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01193504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*